Jefferies Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
9,981
-619
-6% -$163K 0.02% 571
2026
Q1
$2.83M Sell
10,600
-8,024
-43% -$2.17M 0.02% 497
2025
Q4
$4.67M Buy
18,624
+12,824
+221% +$3.41M 0.02% 503
2025
Q3
$1.66M Sell
5,800
-13,200
-69% -$3.54M 0.01% 708
2025
Q2
$4.99M Sell
19,000
-7,796
-29% -$1.9M 0.04% 300
2025
Q1
$6.24M Buy
26,796
+1,283
+5% +$311K 0.06% 239
2024
Q4
$5.85M Buy
25,513
+15,582
+157% +$3.57M 0.04% 316
2024
Q3
$2.22M Sell
9,931
-13,931
-58% -$3.06M 0.02% 565
2024
Q2
$4.86M Buy
23,862
+15,596
+189% +$3.17M 0.05% 300
2024
Q1
$1.81M Buy
+8,266
New +$1.82M 0.02% 629
2023
Q3
– Sell
-7,680
Closed -$1.59M – 1809
2023
Q2
$1.59M Buy
+7,680
New +$1.49M 0.01% 744
2018
Q2
– Sell
-12,331
Closed -$1.71M – 80
2018
Q1
$1.71M Buy
12,331
+8,689
+239% +$1.28M 0.12% 47
2017
Q4
$499K Buy
+3,642
New +$481K 0.04% 66

Other funds holding LH

Jefferies Financial Group's LH Position: Q2 2026 in Review

Jefferies Financial Group reduced its Labcorp (LH) stake by 5.8% in Q2 2026, selling an estimated $163K and leaving 9,981 shares worth $2.79M. The position accounts for 0.02% of the portfolio, ranked #571.

Jefferies Financial Group first reported a position in LH in Q4 2017 and has held it in 13 quarters since. The position peaked at $6.24M in Q1 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Jefferies Financial Group held 9,981 shares of Labcorp worth $2.79M as of Q2 2026.
  • Jefferies Financial Group sold 619 Labcorp shares in Q2 2026, an estimated $163K.
  • Labcorp made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #571 holding.
  • Jefferies Financial Group first reported a position in Labcorp in Q4 2017 and has held it in 13 quarters since.
  • Jefferies Financial Group's Labcorp position peaked at $6.24M in Q1 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.